NASDAQ:IART - Integra Lifesciences Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $51.06 +0.41 (+0.81 %) (As of 02/15/2019 04:00 PM ET)Previous Close$50.65Today's Range$50.44 - $51.2552-Week Range$42.14 - $67.50Volume412,600 shsAverage Volume514,834 shsMarket Capitalization$4.35 billionP/E Ratio26.32Dividend YieldN/ABeta0.89 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Integra Lifesciences (NASDAQ:IART) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.13 Wall Street analysts have issued ratings and price targets for Integra Lifesciences in the last 12 months. Their average twelve-month price target is $61.4167, suggesting that the stock has a possible upside of 20.28%. The high price target for IART is $70.00 and the low price target for IART is $54.00. There are currently 1 sell rating, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.382.382.232.21Ratings Breakdown: 1 Sell Rating(s)6 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)6 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)8 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)9 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $61.4167$61.4167$61.2727$60.75Price Target Upside: 20.28% upside31.88% upside14.19% upside1.96% upsideIntegra Lifesciences (NASDAQ:IART) Consensus Price Target History Integra Lifesciences (NASDAQ:IART) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails1/8/2019Cantor FitzgeraldSet Price TargetHold$54.00Low1/3/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$56.00High12/17/2018Credit Suisse GroupInitiated CoverageOutperform$57.00Medium11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$58.00High11/2/2018CitigroupLower Price TargetNeutral ➝ Neutral$66.00 ➝ $60.00Low11/2/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$66.00 ➝ $62.00Low11/1/2018Wells Fargo & CoLower Price TargetMarket Perform ➝ Market Perform$61.00 ➝ $55.00High10/31/2018OppenheimerReiterated RatingBuy$70.00High10/11/2018Morgan StanleySet Price TargetHold$58.00 ➝ $68.00Low10/11/2018BTIG ResearchReiterated RatingBuy$69.00Medium8/7/2018Bank of AmericaDowngradeNeutral ➝ UnderperformMedium5/22/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$57.00 ➝ $65.00Low3/1/2018Jefferies Financial GroupReiterated RatingBuy$63.00Low1/9/2018BarclaysReiterated RatingHold$53.00Low1/2/2018Raymond JamesReiterated RatingOutperform ➝ Market Perform$55.00Medium11/9/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$48.00 ➝ $50.00N/A3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00Low(Data available from 2/16/2017 forward) This page was last updated on 2/16/2019 by MarketBeat.com StaffFeatured Article: What is dollar cost averaging (DCA)?